Latest filing published 22 May 2026 for Precision Biosciences INC.
Filing timeline
BuySaleInsider track record
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Kevin Buehler: trading record in brief
This profile gathers the share dealings of Kevin Buehler in Precision Biosciences Inc. Between 11 April 2023 and 20 May 2026, the trades on record add up to 7 filings.
Purchases make up the whole of the open-market record (3 purchases, €58k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 option exercises.
A typical purchase (the median) is worth €20k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 22 May 2026 came the latest disclosure, an option exercise in Precision Biosciences Inc. The clock since the last published purchase (27 June 2025) now reads 501 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Buehler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,000 sharesCommon StockSEC:0001628280-26-037539:0
- 5,076 shares@ US$4.16Common StockSEC:0001628280-25-033199:0Canonical exit: 23 Sept 2025 (T+90)
- 9,826 sharesCommon StockSEC:0000950170-25-081725:0
- 4,523 shares@ US$4.6749.2% of flowCommon StockSEC:0000950170-25-046331:0Canonical exit: 24 Jun 2025 (T+90)
- 4,320 shares@ US$4.8850.8% of flowCommon StockSEC:0000950170-24-141309:0Canonical exit: 27 Mar 2025 (T+90)
- 4,202 sharesCommon StockSEC:0000950170-24-054586:0
- 5,701 sharesCommon StockSEC:0001209191-23-024206:0
7 of 7 declarations
